Dexcom
Sign in to saveAlso known as Dexcom, Inc.
Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S.A., and manufacturing facilities in Mesa, Arizona, U.S.A.; Batu Kawan, Malaysia; and Athenry, County Galway, Ireland.
OverviewAI-generated
Dexcom is an active company established in 1999. It operates as an entity within the United States, specifically located in San Diego, and is incorporated in Delaware. The organization functions as both a company and a funder. Its primary industry classification is surgical and medical instruments and apparatus.
The firm is listed on the Nasdaq exchange under the ticker symbol DXCM. It holds the Central Index Key 0001093557 and adheres to a fiscal year ending on December 31. Dexcom is recognized in the Sp 500 collection. Its latest filing form was 144, dated June 4, 2026.
Synthesized by Vinony from 23 facts across 5 sources: Wikidata, Firecrawl, SEC EDGAR, ROR, Vinony collections. Generated from structured data (not the Wikipedia text) and checked against those facts — may still contain errors.
Company
DXCM- Industry
- Surgical & Medical Instruments & Apparatus
- Exchange
- Nasdaq
- State of incorporation
- DE
- Entity type
- operating
- Jurisdiction
- US-DE
- Headquarters
- San Diego, US
Research organization · ROR
- Type
- Company, Funder
- Founded
- 1999
- Location
- San Diego, United States
- Status
- Active
GRID grid.480089.d · ISNI 0000 0004 6007 3973
Wikidata facts
- Instance of
- public company
- Part of
- S&P 500
- Country
- United States
- Headquarters
- San Diego
- Stock exchange
- Nasdaq
- Legal form
- Delaware corporation
- Official website
- dexcom.com
Show 3 more facts
- inception
- 1999-00-00
- product or material produced
- medical device
- social media followers
- 46700
via Wikidata · CC0